Miso, Facts are indeed stranger than fiction. The article is clear proof GSK outsmart Peter Cook the idiot and complete fool (or is it? Peter Cook has a history of proven successess in wealth creation!). Immediately upon settlement, GSK started selling Relenza call options for which BTA get ZERO royalty.
In the seasonal flu market, GSK's prime interest is in the selling of Flu Vaccines.
QUOTE:Peter crushed them into submission, making them promise to do better in exchange for our $300 million.
LOL. Many shareholders believe that movements in some Swiss Bank accounts were the likely exchanges.
Peter Cook and his mates on the BTA board continue to treat shareholders with complete contempt. They initially blamed Peter Molloy for the GSK law suit lossess. They then tried to fool shareholders with the stupidiest reasons for the settlement.
To top up the insult, they rewarded the BTA executives with more and more options and engaged in BTA shares buyback for these options.
BTA Price at posting:
43.0¢ Sentiment: Sell Disclosure: Not Held
